DRG-driven change in burn wound management: a success story.
We have devised an algorithm employing the exclusive use of biosynthetic dressing (Biobrane) to treat the less extensive burn wounds of patients under DRG 460. This protocol has allowed us to decrease the hospital stay of these patients by 46 percent and turn this patient group from a deficit for the hospital to a substantial profit.
D001672:Biocompatible Materials; D002056:Burns / Q000097:blood / Q000191:economics / Q000628:therapy*; D020099:Coated Materials, Biocompatible; D003365:Costs and Cost Analysis; D003953:Diagnosis-Related Groups; D006801:Humans; D007902:Length of Stay; D009779:Occlusive Dressings
C042816:Biobrane; D001672:Biocompatible Materials; D020099:Coated Materials, Biocompatible